I’m not quite sure why, but the blogosphere is increasingly chattering again about relaxing the rules against infringing a patent by making the protected product (esp. a pharmaceutical) for export:
IP’s What’s Up reviews the TRIPS status including the DOHA declaration and its rather tentative take up.
